Gonadorelin is a gonadotropin releasing hormone agonist that has shown benefit in the treatment of infertility and hypogonadism. Recent research suggests that gonadorelin may be useful in slowing the growth of breast and prostate cancer. Studies also show promise in the treatment of Alzheimer’s disease.
Gonadotropin-Releasing Hormone for Endocrine Studies
Gonadorelin is a synthetic analog of naturally occurring gonadotropin-releasing hormone (GnRH), essential for research into reproductive endocrinology and hormone regulation pathways. This research peptide enables investigation of pituitary-gonadal axis functions.
Research Focus:
- GnRH receptor studies
- Reproductive endocrinology research
- Hormone regulation pathway analysis
- Pituitary function investigations
- Gonadotropin release studies
Product Characteristics:
- Synthetic GnRH analog
- High receptor affinity
- Stable peptide formulation
- Research-validated purity
Intended for scientific research only.
Gonadorelin 10mg - GnRH Research Analog
₹17,000.00Price
- Typical dosages can range, but commonly it’s 2mg per vial, which can be reconstituted with sterile water.
- The peptide is typically administered via subcutaneous injection.
- The dosing regimen often involves one injection per week, as it has a prolonged half-life (due to the DAC component).
- As with any peptide, there could be risks, such as injection site reactions, water retention, or possible changes in insulin sensitivity.
- It’s important to monitor health regularly and consult with a healthcare provider, especially if using for long-term purposes.
